3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
3
Recurrence
2
Pleural Effusion, Malignant
2
Mesothelioma, Malignant
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
NSCLC
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lymphedema
1
Leukemia, Myeloid, Chronic-Phase
1
Immunoglobulin Light-chain Amyloidosis
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Glioblastoma
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Dysplastic Nevus Syndrome
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Methylprednisolone
3
Social Determinants of Health
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
pegaspargase
1
Vincristine
1
Temozolomide
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Pharmaceutical Services
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Irinotecan
1
Infliximab
1
Hydrocortisone
1
Fecal Microbiota Transplantation
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Cefixime
1
CTLA-4 Antigen
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Pharmaceutical Preparations
×
1 year
×
Clear all
No trials found.